LITERATURE SUMMARIES, ASSESSMENTS, FOR BEST PHARMACEUTICALS FOR CHILDREN ACT

NICHD受美国国立卫生研究院委托，负责执行国会授权的《2002年儿童最佳药品法》，该法案于2007年重新授权。NICHD负责对儿童使用但缺乏足够的儿科标签的优先、非专利药物的临床试验。排雷中心的责任包括行政活动和支持，以及协调支持和参与BPCA活动的其他IC。这个项目的功能是为BPCA提供文献综述、评估和荟萃分析。用于对儿童进行药理学研究的数据。

The NICHD, as delegated by the NIH, is responsible for implementing the Congressionally-mandated Best Pharmaceuticals for Children Act of 2002, as reauthorized in 2007. The NICHD is responsible for the performance of clinical trials of priority, ¿off patent¿ drugs that are used in children but that lack sufficient pediatric labeling. NICHD responsibility includes administrative activities as well as support, and coordinating support and participation of other ICs in BPCA activities. The function of this project is to provide literature summaries, assessments, and meta-analysis for the BPCA. Data used to conduct pharmacology studies in children.